Home
Vivo Opportunity Fund Holdings reported a 8% stake in AN2 Therapeutics ANTX · 2,864,346 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 8%
- Last report
- First report
- Shares held
- 2,864,346 sh
- Class
- Common Stock, par value $0.00001 per share
- Event date
- 26/03/10
- Filed
- 26/03/13
First 5%+ report · 8% stake
AN2 Therapeutics trades, last 26 weeks
What else happened in AN2 Therapeutics around then
Filed or reported within 30 days of the trade day · 02/08~04/09Vivo Opportunity Fund Holdings's other 5% stake reports
- Vivo Opportunity Fund Holdings
5% stakeCompass Therapeutics
5% stakeCompass Therapeutics
CMPX
4% stake
7,207,573 sh
4% stake
Filed 08/14
- Vivo Opportunity Fund Holdings
5% stakeEntera Bio
5% stakeEntera Bio
ENTX
6.9% stake
11,817,401 sh
6.9% stake
Filed 08/04
- Vivo Opportunity Fund Holdings
5% stakeAchieve Life Sciences
5% stakeAchieve Life Sciences
ACHV
5% stake
5,305,640 sh
5% stake
Filed 07/08
- Vivo Opportunity Fund Holdings
5% stakeInMed Pharmaceuticals
5% stakeInMed Pharmaceuticals
INM
21.7% stake
718,444 sh
21.7% stake
Filed 06/10
- Vivo Opportunity Fund Holdings
5% stakeDBV Technologies
5% stakeDBV Technologies
DBVT
4% stake
11,820,005 sh
4% stake
Filed 05/12
